CCL21 and B-cell chronic lymphocytic leukemia: Redondo-Muñoz et al. [33] initially discovered that the migration of B-cell chronic lymphocytic leukemia cells, induced by CCL21, could be inhibited by using anti-CCR7 antibodies, CCR7 siRNA transfection, or ERK inhibitors.